By Staff Reporters
***
***
Walgreens tapped Mary Langowski, a former CVS Health executive, to lead its U.S. healthcare segment. The move comes as the retail pharmacy giant looks to boost profitability in its healthcare business.
CVS Health cut its outlook for 2024 on the back of higher medical costs in the fourth quarter. The drugstore chain, which owns Aetna, joins other healthcare companies to see a spike in utilization.
And … following up on a federal law passed in September to increase competition among organ transplant contractors, HRSA is issuing requests for proposals for several different contracts.
CITE: https://www.r2library.com/Resource
COMMENTS APPRECIATED
Thank You
***
***
Filed under: "Advisors Only", "Doctors Only", Accounting, Breaking News, Drugs and Pharma, Ethics, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, Interviews, Investing, Managed Care | Tagged: Aetna, CVS Health, HRSA, human organs, Mary Langowski, organ transplants, walgreens |















Leave a comment